Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02272387 · ClinicalTrials.gov registry record · NA
Is Vitamin D Insufficiency and Deficiency Associated With Antepartum and Postpartum Depression?
A NA study, sponsored by St. Luke's-Roosevelt Hospital Center.
- Terminated
- Registry status
- NA
- Development phase
- 151
- Enrollment target
NCT02272387: Clinical Trial NA study, sponsored by St. Luke's-Roosevelt Hospital Center.
NCT02272387 is a NA study that was terminated before completion, run by St. Luke's-Roosevelt Hospital Center. The registered enrollment target is 151 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02272387, a NA study, was terminated before completion, sponsored by St. Luke's-Roosevelt Hospital Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 151 participants
- Enrollment target
Study Summary
Our primary aim is to evaluate whether Vitamin D deficiency causes depressive symptoms in antepartum and postpartum depression and whether early correction of Vitamin D deficiency improves these symptoms. Our secondary aims evaluate maternal and fetal outcomes including antepartum, intrapartum, and immediate postpartum complications. We are also evaluating the effectiveness of a common vitamin D treatment regimen used outside of pregnancy.
Primary Outcome
We will be using an Edinburgh Postnatal Depression Scale (EPDS) questionnaire to monitor depressive symptoms.
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Vitamin D3 (Cholecalciferol)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 151 participants |
| Start Date | 2014-10 |
| Est. Completion | 2016-04-14 |
| Phase | NA |
Why NCT02272387 stopped before completion
NCT02272387 is an interventional study that assigns participants to a tested intervention. The registered 151 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02272387 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02272387 about?
NCT02272387 is a clinical study titled "Is Vitamin D Insufficiency and Deficiency Associated With Antepartum and Postpartum Depression?". Our primary aim is to evaluate whether Vitamin D deficiency causes depressive symptoms in antepartum and postpartum depression and whether early correction of Vitamin D deficiency improves these symptoms. Our secondary aims evaluate maternal and fetal outcomes including antepartum, intrapartum, and...
What is the current status of trial NCT02272387?
This trial is currently terminated. It is a NA study. The enrollment target is 151 participants. The study started on 2014-10. Estimated completion is 2016-04-14.
What interventions are being tested in trial NCT02272387?
The interventions under investigation include: Placebo (OTHER), Vitamin D3 (Cholecalciferol) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02272387?
This trial is sponsored by St. Luke's-Roosevelt Hospital Center, which has 57 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02272387's enrollment target sits among peer trials
151 661st of 2000 higher than 1,340 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01409161 · 151 participants · Phase 2
Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
- NCT04245397 · 151 participants · Phase 1
Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome
- NCT05761223 · 151 participants · Phase 1
A Phase I/II, Open-label Study to Investigate the Safety, Tolerability, PK, and Preliminary Efficacy of FB849
- NCT07195656 · 151 participants · NA
Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia